1. Zantac – From 15 Million Prescriptions a Year to Being Pulled Off Shelves for Possible Carcinogen Ingredient

    In September 2019, the FDA announced that ranitidine (Zantac), prescribed for heartburn, contained low levels of N-nitrosodimethylamine (NDMA), which is considered to be a likely human carcinogen. Drug companies that have recalled their ranitidine products include Novartis and Apotex. Drugstore chain Walgreens is pulling Zantac and other ranitidine-based products off its shelves. FDA made the anno…Read More